Current Rheumatology Reports

Papers
(The TQCC of Current Rheumatology Reports is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
COVID-19 and Myositis: What We Know So Far102
A Review of Complement Activation in SLE89
Systemic Lupus Erythematosus in Children and Young People78
Epidemiology of Antiphospholipid Syndrome in the General Population70
T Cell Abnormalities in the Pathogenesis of Systemic Lupus Erythematosus: an Update62
Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease36
Fatty Acids and Oxylipins in Osteoarthritis and Rheumatoid Arthritis—a Complex Field with Significant Potential for Future Treatments35
Diffuse Idiopathic Skeletal Hyperostosis (DISH) and a Possible Inflammatory Component35
Current Epidemiology and Risk Factors for the Development of Hand Osteoarthritis34
Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens34
The Use of COVID-19 Vaccines in Patients with SLE34
Clinical Approach to Diagnosis and Therapy of Polyarteritis Nodosa32
Advances in the Treatment of Behcet’s Disease32
Dietary and Lifestyle-Centered Approach in Gout Care and Prevention31
Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides30
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?29
Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled Trials29
T cell Repertoire Profiling and the Mechanism by which HLA-B27 Causes Ankylosing Spondylitis28
Re-Examining Myofascial Pain Syndrome: Toward Biomarker Development and Mechanism-Based Diagnostic Criteria26
Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future25
Updates on the Immunopathology in Idiopathic Inflammatory Myopathies24
Hyperuricemia, Gout, and the Brain—an Update24
Mitochondria in the Pathogenesis of Systemic Lupus Erythematosus24
Involvement of Macrophages and Spinal Microglia in Osteoarthritis Pain23
An Update on Antiphospholipid Syndrome22
Axial Psoriatic Arthritis22
Metabolic Regulation of Tendon Inflammation and Healing Following Injury22
The Musculoskeletal Manifestations of Marfan Syndrome: Diagnosis, Impact, and Management21
Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis21
IgA Vasculitis in Adults: a Rare yet Challenging Disease21
Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist21
Etiologies of Rheumatoid Arthritis: Update on Mucosal, Genetic, and Cellular Pathogenesis21
Future of Low-Dose Computed Tomography and Dual-Energy Computed Tomography in Axial Spondyloarthritis21
Gut Microbiota in Lupus: a Butterfly Effect?20
SARS-CoV-2 and Systemic Lupus Erythematosus20
A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis?20
Self-Management of Rheumatoid Arthritis: Mobile Applications19
Novel Therapies for ANCA-associated Vasculitis18
TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals18
Exogenous miRNA: A Perspective Role as Therapeutic in Rheumatoid Arthritis18
A Spotlight on Drug-Induced Vasculitis18
ANCA Status or Clinical Phenotype — What Counts More?18
Who Would Have Predicted Multisystem Inflammatory Syndrome in Children?17
Imaging of Joint and Soft Tissue Involvement in Systemic Lupus Erythematosus17
Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections)17
Update on Uric Acid and the Kidney16
Modification of Gut Microbiota in Inflammatory Arthritis: Highlights and Future Challenges16
The Role of Antiphospholipid Antibodies in COVID-1916
JAK Inhibitors for Axial Spondyloarthritis: What does the Future Hold?15
COVID-19 and Disease-Modifying Anti-rheumatic Drugs15
Autonomic Nervous System Dysregulation and Osteoarthritis Pain: Mechanisms, Measurement, and Future Outlook15
Mesangial Cells in Lupus Nephritis15
NETosis in Rheumatic Diseases15
0.66030812263489